Skip to main content
Premium Trial:

Request an Annual Quote

International Finance Corporation Invests $16.5M in MedGenome to Boost COVID-19 Testing in India

NEW YORK ─ International Finance Corporation is investing $16.5 million in MedGenome, a genetic diagnostics and research company, to increase access to COVID-19 testing in India, the companies said on Thursday.

The equity investment will also support research to help better understand the COVID-19 virus and its variants, and to manage future outbreaks, the firms said.

"With IFC's support, we will continue to expand our services across India, bringing tests directly to the communities most affected by the pandemic, and finding genetic variants that might be making some people more susceptible to severe COVID-19 infection and post-COVID illness," Sam Santhosh, MedGenome's founder and chairman, said in a statement.

IFC's investment will support the expansion of MedGenome's diagnostic services and increase the collection of genomic data from South Asian populations to provide insights into complex diseases, the firms said.

Washington, D.C.-based IFC, a member of the World Bank, is a global development institution focused on the private sector in developing countries. The investment in Foster City, California-based MedGenome is part of IFC's $4 billion Global Health Platform, which provides financing to support the manufacturing and supply of vaccines, medical equipment, and therapeutics, as well as logistics to deliver vaccines and medications.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.